OverviewSuggest Edit

AtriCure provides atrial fibrillation solutions to medical centers. The Company offers innovative solutions for ablation, such as Isolator Synergy and Isolator Synergy Access clamps, COBRA Fusion surgical ablation system and EPi-Sense guided coagulation system. It also provides SUBTLE cannula, multifunctional pens and linear ablation devices. In addition, the Company offers cryoICE cryoablation system, AtriClip system, Lumitip dissector and Estech cardiac surgery instruments.
TypePublic
Founded2000
HQMason, US
Websiteatricure.com
Employee Ratings4.1

Latest Updates

Employees (est.) (Jan 2020)730(+18%)
Job Openings18
Revenue (FY, 2019)$230.8 M(+15%)
Share Price (Sept 2020)$38.5 (-1%)
Cybersecurity ratingCMore

Key People/Management at AtriCure

Michael H. Carrel

Michael H. Carrel

President and Chief Executive Officer
Douglas Seith

Douglas Seith

COO
Justin Noznesky

Justin Noznesky

Senior Vice President, Marketing and Business Development
Douglas J. Seith

Douglas J. Seith

Chief Operating Officer
Andrew Wade

Andrew Wade

Senior Vice President and Chief Financial Officer
Show more

AtriCure Office Locations

AtriCure has offices in Mason, Albany, Allen, Allentown and in 22 other locations
Mason, US (HQ)
7555 Innovation Way
Albany, US
Albany, NY, USA
Allen, US
Allen, TX, USA
Allentown, US
Allentown, PA, USA
Boston, US
Boston, MA, USA
Chicago, US
Chicago, IL, USA
Show all (27)

AtriCure Financials and Metrics

AtriCure Revenue

Embed Graph
View revenue for all periods
AtriCure's revenue was reported to be $230.81 m in FY, 2019
USD

Revenue (Q2, 2020)

40.8m

Gross profit (Q2, 2020)

27.7m

Gross profit margin (Q2, 2020), %

67.7%

Net income (Q2, 2020)

(8.2m)

EBIT (Q2, 2020)

(7.3m)

Market capitalization (23-Sept-2020)

1.7b

Closing stock price (23-Sept-2020)

38.5

Cash (30-Jun-2020)

88.5m

EV

1.7b
AtriCure's current market capitalization is $1.7 b.
USDQ2, 2011

Financial Leverage

2.1 x
Show all financial metrics

AtriCure Acquisitions / Subsidiaries

Company NameDateDeal Size
SentreHEARTAugust 15, 2019$300 m

AtriCure Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

AtriCure Online and Social Media Presence

Embed Graph

AtriCure News and Updates

Ablation Technologies Market Size, Growth rate, Market Statistics and Future Forecasts to 2023

The report depicts the global and regional total market of Ablation Technologies industry including capacity, production, production value, cost/profit, supply/demand and import/export details. Posted via Industry Today. Follow us on Twitter @IndustryToday

New Research Report On Epicardial LAA Closure Device Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, to 2021, Focusing on Top Key Vendors like AtriCure, Boston Scientific, St. Jude, Coherex Medical, Lifetech Scientifi

Epicardial LAA (Left Atrial Appendage) Closure Device Market by Product (Epicardial LAA Closure Device and Endocardial LAA Closure Device) and End User (Hospitals, Ambulatory Surgical Centers, and Heart Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2021Top Companies Profiled in …

Left Atrial Appendage (LAA) Closure Devices Market to Make Great Impact in Near Future by 2025

The North America is dominating and contributed the leading shares to the global left atrial appendage (LAA) closure devices market in terms of revenue and expected to register a significant growth during forecast period. Posted via Industry Today. Follow us on Twitter @IndustryToday

AtriCure Blogs

AtriCure, Inc.'s cover photo

[ AtriCure, Inc. ] Reference Source

Where a Sore Throat Becomes a Death Sentence

[ AtriCure, Inc. ]Once a year, doctors travel to Rwanda to perform lifesaving surgery on people with damaged heart valves — a disease caused by untreated strep throat.Reference Source

No title

[ AtriCure, Inc. ]AtriCure employees in Minneapolis spent time learning CPR and how to use an AED from the American Heart Association - Minnesota. So far this year, 170 AtriCure employees have been trained on how to react in a cardiac emergency - further proving that our dedication to saving lives i…

Photos from AtriCure, Inc.'s post

[ AtriCure, Inc. ] Reference Source

AtriCure, Inc.

We are gratified to #help launch the school year by #supporting #Cincinnati Woodford Paideia Academy #teachers by d… https://t.co/j6JMfXnQwG Reference Source

AtriCure, Inc.

RT @DeBosPeter: @AtriCure with Mike Rogge and Jack Wesley at our warehouse in the Netherlands....One AtriCure Family https://t.co/4FDSzyRSwz Reference Source
Show more

AtriCure Frequently Asked Questions

  • When was AtriCure founded?

    AtriCure was founded in 2000.

  • Who are AtriCure key executives?

    AtriCure's key executives are Michael H. Carrel, Douglas Seith and Justin Noznesky.

  • How many employees does AtriCure have?

    AtriCure has 730 employees.

  • What is AtriCure revenue?

    Latest AtriCure annual revenue is $230.8 m.

  • What is AtriCure revenue per employee?

    Latest AtriCure revenue per employee is $316.2 k.

  • Who are AtriCure competitors?

    Competitors of AtriCure include GATT Technologies, Dianosic and Medistim.

  • Where is AtriCure headquarters?

    AtriCure headquarters is located at 7555 Innovation Way, Mason.

  • Where are AtriCure offices?

    AtriCure has offices in Mason, Albany, Allen, Allentown and in 22 other locations.

  • How many offices does AtriCure have?

    AtriCure has 27 offices.